Medications Flashcards

1
Q

Benzodiazepines
- MOA
- Characteristics
- Systemic effects
- Metabolism
- Reversal

A
  • Bind to inhibitory GABA receptors in brain (cerebral cortex), increasing inward Cl- flow–> hyperpolarization and reduction in neuronal transmission.
  • Sedation, anxiolysis, anterograde amnesia, muscle relaxant, anticonvulsant, NO analgesia
  • Decrease BP and HR, large bolus can induce unconsciousness and apnea. Small doses can cause respiratory depression
  • Metabolized via hepatic enzymes, some clinically active. Excreted by kidney.
  • Flumazenil is reversal agent, can combat paradoxical excitement, excessive sedation and respiratory depression
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Diazepam

A

–Valium (Benzo)
Highly lipid soluble, carried in organic solvent (propylene glycol or soybean oil emulsion. Injection can be painful. Numerous active metabolites and longer elimination time (t1/2 is 24-96H). Metabolites are partially eliminated in bile, may have recurrent effects with fatty meals.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Midazolam

A

– Versed (Benzo)
Lipid soluble, able to be delivered in a aqueous acidic solution (less pain on IV/ IM administration). 2-3X more potent than Diazepam with faster onset, elimination and decreased lingering effects. Minimal active metabolites. Monitor for respiratory depression.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Lorazepam

A

–Ativan (Benzo)
Long acting benzo with slow onset. Commonly given night prior to surgery for pre-op anxiolysis. Metabolized via glucuronidation with no active metabolites (does not use CYP-450). Excellent emergency anticonvulsant.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Triazolam

A

–Halcion (Benzo)
Sleep adjunct used for off label anxiolysis and moderate sedation. Only oral form available. Very short acting (~2 hours).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Remimazolam

A

–Byfavo (Benzo)
Ultra short acting benzo. undergoes hydrolysis via tissue esterase’s.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Flumazenil

A

–Anexate, Lanexat, Mazicon, Romazicon
Competitive antagonist for benzo reversal of sedation, disinhibition and respiratory depression. Given at 0.2 mg initially followed by 0.1 mg at 1 min intervals up to 1 mg. Emergency dose 0.5-1 mg bolus. Effects last 30-60 min and may require redosing (other drugs may out last flumazenil). Caution with epileptics who are on chronic benzo use.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Opioids
- MOA
- Characteristics
- Systemic effects
- Metabolism
- Reversal

A
  • bind to opioid receptors. Agonistic activity modifies or decreases neuronal transmission of pain signals. Mu (u) and Kappa (k) receptors are predominately responsible for analgesia (1* u)
  • analgesia and augmentation of sedation and euphoria. NO amnesia, sedation, or LOC.
  • Respiratory depression/ arrest is most common side effect and can be exasperated with benzos, barbiturate’s, Propofol and other opioids. Bradycardia due to centrally mediated vagal response at higher doses. Suppress cough reflex, caution with asthmatic patients due to possible histamine release, resulting in decreased BP 2/2 vasodilation, pruritus and erythema. Other effects N/V, constipation, urinary retention, biliary tract spasm (may be misinterpreted as an allergic rxn)
  • Most opioids are metabolized via hepatic enzymes and excreted into bile and urine. *** exception is Remifentanil, which is metabolized by plasma esterase’s
  • Naloxone is reversal agent
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Morphine

A

–Morphine (Opioid)
Poor lipid solubility–> slow onset. Effects last 3-4 h. Commonly used for post-op pain over procedural sedation. Histamine release can cause flushing and decreased BP. Metabolized by hepatic enzymes into two metabolites eliminated by kidney. Caution if compromised renal fxn.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Hydromorphone

A

–Dilaudid, Exalgo (Opioid)
A keytone derivative of morphine with a more rapid onset (2-5 min). x8 more potent than morphine (i.e. 1.2 mg = 10 mg morphine). No histamine release and no active metabolites

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Meperidine

A

–Demerol (Opioid)
Synthetic opioid with rapid onset and 2-3 h duration. Used for post-op pain and Iv sedations. Active metabolite (normeperidine) that is potentially toxic to CNS. Post sedation delirium possible, especially in elderly. Accumulation of normeperidine in renally compromised pts may lead to seizures. Mixed with MAO-i it may cause serotonin Sx. Associated with significant histamine release. Not associated with bradycardia, may cause an INCREASE in HR, possible xerostomia. Rarely used in USA unless for post-op shivering (against k receptor).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Fentanyl

A

–Fentanyl (Opioid)
A synthetic opioid with high lipid solubility and high potency. Rapid onset (~1 min) and short duration of action (10-20 min). Does not induce histamine release, so no vasodilatory or bronchospastic effects. More pronounced bradycardia than morphine. Potent respiratory depressant. Possible chest wall and glottic rigidity (tx with naloxone or paralytic’s)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Remifentanil

A

–Ultiva (Opioid)
Synthetic fentanyl derivative. Rapid duration and extremely short duration of action (decreasing recovery time). Metabolized by nonspecific plasma esterases, clearance is rapid and independent of both renal and hepatic functions. Due to short duration of action, this will offer NO post-op pain control, must supplement with something. Possible “remifentanil-induced hyperalgesia” due to acute withdrawn of medication. Potent respiratory depression and may cause chest wall rigidity,

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Naloxone

A

–Narcan
Pure opioid antagonist active at all opioid receptor subtypes. Reversal of both ventilatory depressive and analgesic effects. Can also reverse chest wall and glottic rigidity. Use with caution if pt is on chronic opioids (pain management/ illicit use or methadone), may result in acute withdrawals or acute congestive HF. Initial dose is 0.4-2 mg IV or titrated in0.04 mg increments. Duration of action is 30-45 min, so watch for reemergence of respiratory depression.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Propofol

A

–Propofol (Sedative)
Highly lipid soluble suspension in soybean oil, glycerol and egg phosphatide (egg protein is lecithin, most allergies are to egg albumin). Thought to act on GABA receptor. High doses can cause amnesia and LOC, also an anticonvulsant. 1.5-2.5 mg/ Kg for induction. In OMFS 10-30 mg bolus are given. Commonly used in conjunction with Benzo’s and opioids. Metabolized by hepatic enzymes, however rate of clearance exceeds hepatic blood flow. May decrease systemic BP by 20-40%. Blocks sympathetic tone allowing parasympathetic tone to dominate, blunting reflex tachycardia. Causes dose dependent respiratory depression. No histamine release. Rapid wake up with less CNS effects, possible euphoria on wake up. Decreased PONV. Due to large size of molecule, pain present when injected into smaller vessels. If open discard after 12 hours. EDTA is used in medication as antibacterial, may exasperate sulfite sensitives. No reversal agent.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Phenobarbital

A

–Phenobarbital (Barbiturate)
Short acting barbiturate. Legal and cost considerations limit use. No reversal.

13
Q

Methohexital

A

–Methohexital (barbiturate)
ultrashort acting, used prior to Propofol. High hepatic clearance. Associated with myoclonus and hiccupping. May activate seizure foci, caution in epileptics. Insignificant histamine release

13
Q

Etomidate

A

–Etomidate (Sedative)
Water soluble, acts on GABA. Primarily an induction agent. Advantage is cardiovascular stability. BP may decrease up to 15%, changes in HR are minimal. Usually used in pts with unstable CV disease. Respiratory depression possible at higher doses but is typically maintained. Metabolized by hepatic enzymes and plasma esterase’s. Quick wake ups. Myoclonus present in >50% of pts. Pain on injection and is associate with adrenocortical suppression. No reversal agent.

13
Q

Thiopental

A

–Thiopental (barbiturate)
Ultra short acting, used for LOC prior to ETT. May release histamine, concern in asthmatics. NOT USED IN USA.

13
Q

Ketamine

A

–Ketamine (Sedative)
Causes dissociation between thalamocortical and limbic system producing a cataleptic state. Has anterograde amnesia and analgesic properties. Exact mechanism is unclear but ketamine is an agonist of NDMA receptors (subset of glutamate receptors). Highly lipid soluble, quick on and quick off. Metabolized by hepatic enzymes with active metabolite (norketamine). Increases HR and BP (caution in pts with uncontrolled BP or tachycardia). Ketamine is actually a direct myocardia depressant. No a respiratory depressant but possible at large doses. Increases salivation and may be emetogenic. No histamine release, potent bronchodilator. Ketamine dart is 2-3 mg/kg for IV placement. Monitor for “emergence delirium”. No reversal agent.

13
Q

Inhalational anesthetics
- MOA
- Characteristics
- Systemic effects
- Metabolism
- Reversal

A
  • N2O and volatile halogenated agents (isoflurane, sevoflurane and desflurane)
  • Inhaled agents able to cross BBB. Titrated to effect via MAC, but exact MOA is undetermined.
  • Halogenated agents are complete anesthetics providing hypnosis, amnesia, analgesia and muscle relaxation.
  • All produce generalized CV depressant effects, thus lowering MAP. Halogenated agents produce rapid and shallow breathing, leading to increased CO2. Concern for MH (NOT with N2O).
  • Minimally metabolized and are eliminated back into alveoli.
  • No reversal agents
13
Q

Barbiturates
- MOA
- Characteristics
- Systemic effects
- Metabolism
- Reversal

A
  • Direct agonist of GABA receptors
  • Produce sedation, LOC and amnesia. No analgesia. Can be used as anticonvulsants. Used in prevention and Tx of seizure’s.
  • Dose dependent decrease in RR. Peripheral vasodilation leads to drop of 10-30% in BP. Intraarterial injection can cause painful arterial spasm, precipitate’s of barbiturate’s crystals can damage endothelium leading to vascular occlusion.
  • Metabolized by hepatic enzymes with no active metabolites and are cleared renally
  • No reversal agents
13
Q

Isoflurane

A

–Isoflurane (Inhalational anesthetic)
Intermediate potency (MAC 1.2). Leads to frequent gagging and coughing. More cost effective than Sevo or Des. Very few contraindications.

13
Q

Sevoflurane

A

–Sevoflurane (Inhalational anesthetic)
Non pungent, intermediate potency (MAC 2-2.4). Short recovery. No associated renal damage. Sevo and CO2 scrubbers produce a degradation product called “compound A,” a haloalkane that is nephrotoxic in rats, but has not been shown so in humans. Caution with use in renal pts.

13
Q

Nitrous Oxide

A

–N2O (inhalational anesthetic)
Used for anxiolysis and mild sedation. May get respiratory depression or airway obstruction. Possible PONV. With healthy pts, diffusion hypoxia is highly unlikely. Rapid on, rapid off. Can enter closed spaces faster than nitrogen can exit, leading to distention of the space. Do not use in pts with otitis media, sinus infections, advanced COPD, pts with URI or severe PONV. Possible sexual hallucinations (have someone in room). Kick pregnant personnel out of room due to risk of spontaneous abortion.

13
Q

Neuromuscular blocking agents (NMBs)
- MOA
- Characteristics
- Systemic effects
- Metabolism
- Reversal

A
  • All are competitive antagonists that bind to nicotinic ACh receptors located on post synaptic membrane of NMJ of skeletal muscles, thus interfering with muscle contraction.
  • Many derived from curare. Can be “depolarizing” or “nondepolarizing”
  • Nondepolarizing do not induce contractions and are classified into benzylisoquinolones (may trigger histamine release–> flushing and peripherial vasodilation) and aminosteroids (may block vagal activity causing increased HR).
  • May induce MH.
  • Depolarizing metabolized buy pseudocholinesterase and nondepolarizing metabolized by liver and kidney
  • Sugammadex reverses rocuronium and vecuronium.
    *see individual drug cards for more info
14
Q

Rocuronium

A

–Rocuronium (nondepolarizing NMB)
Not as rapid as SCh, it is the fastest nondepol. NMB with paralysis occurring around 60s. Monitored by TOF. Reversed by anticholinesterase or sugammadex.

14
Q

Desflurane

A

–Desflurane (Inhalational anesthetic)
Extremely pungent and can irritate airways precipitating laryngospasms. Avoided in inhalation inductions. Possible tachycardia. Lowest blood-gas solubility coefficient of any inhalational agent, even N2O–> quick on and quick off. Most expensive inhalational agent. Monitor for airway fires due to exothermic rxn with the scrubber granules.

14
Q

Halothane

A

–Halothane (Inhalational anesthetic)
No longer available in USA. Risks of increased cardiac dysrhythmias and myocardial depression among other things. Used around the world for low cost and inhalation induction is well tolerated

14
Q

Succinylcholine

A

–Succinylcholine (Depolarizing NMB)
Only depolarizing NMB used today. Once SCh bonds to ACh receptor, memb depolarizes and muscle contracts. Contractions are then delayed until SCh dissociates from receptor and is metabolized by pseudocholinesterase. Fastest onset (30-60s) and short duration (5-10 min) of NMBs. Used to Tx laryngospasms not relieved with positive pressure (dose of 20 mg to 1 mg/kg). Not used to maintain intra-op paralysis. Tachycardia on administration but can cause bradycardia with repeat dosing. Post-op myalgia, due to constant contractions. May increase intraocular and intragastric pressures. Trigger for MH and do not use in pts with pseudocholinesterase abnormalities due to prolonged recoveries.

15
Q

Anticholinesterases

A

–Neostigmine and edrophonium
Used to reversed nondepol. NMBs via competitive inhibition. Can lead to bradycardia, bronchospasm, abdominal cramping and excessive salivation. To conbat these effects administer atropine or glycopyrrolate (which will block muscarinic but not nicotinic ACh receptors)

16
Q

Anticholinergics

A

Glycopyrrolate- a quaternary ammonium compound that can not cross BBB.
Atropine and scopolamine- both tertiary amines can cross BBB and cause sedation.

17
Q

Sugammadex

A

–Bridion (NMB reversal agent)
Acts to engage free NMB molecules that would otherwise competitively antagonize the nicotinic ACh receptors of the NMJ. Structure is a gamma-cyclodextrin ring designed to encapsulate particles of rocuronium and vecuronium (2.5x greater affinity to roc than vec) preventing further NMB blockade. Entire complex is then excreted renally. Has rapid reversal. Used to Tx laryngospasms.

18
Q

NSAIDs

A

Inhibit enzyme cyclooxygenase (COX) which acts on arachidonic acid, a breakdown product of phospholipids in cell walls, to produce prostaglandins, an inflammatory mediator involved in pain transmission. Ketorolac tromethamine (Toradol) and ibuprofen (Caledolor) are the two IV NSAIDs used in USA. Toradol has no respiratory depression, nausea or sedation. Ibuprofen may cause NSAID-induced inhibition of platelet aggregation. Caution with bleeding and renal pts and pts with atherosclerotic disease

19
Q

Acetaminophen

A

–Paracetamol, APAP, Tylenol
MOA is undetermined, but uses alternative method from NSAIDs and opioids. Produces analgesia and antipyretic effects, but lacks anti-inflammatory properties. MRD 4K mg/ day. Hepatic metabolism and via CYP-450 enzymes leading to highly reactive toxic metabolite, N-acetyal-para-benzoquione imine (NAPQI), which can lead to hepatic failure. If on Warfarin, MRD is 2000 mg/ day

20
Q

Alpha-2-agonists

A

–Clonidine, Dexmedetomidine (Precedex)
Sedative, analgesic and muscle relaxing properties in addition to inhibition of CNS sympathetic outflow (anti-HTN effects). Able to decrease anesthetic requirements. Clonidine (anxiolytic premed with CV stability) and Dexmedetomidine (8x more selective than Clonidine for alpha-2-receptor). Dexmedetomidine may cause initial HTN but bradycardia is most significant event

21
Q

Antiemetics

A

Act by blocking receptors at the chemoreceptor trigger zone (CRTZ) in the medulla. phenothiazines (Prochlorperazine) and butyrophenones (Droperidol) block the dopamine receptors but may have sedative and extrapyramidal. At larger doses may prolong QT interval. Ondanstron, dolasetron and granistron are serotonin; 5-HT antagonists with less sedative effects.
Antihistamines (promethazine), anticholinergics (scopolamine, hydroxyzine and diphenhydramine) help with PONV. Newest antiemetic is an NK1 receptor antagonist, aprepitant (Emend) is useful for delayed PONV. Dexamethasone (corticosteroid) and Propofol also have PONV effects

22
Q
A